Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
7
7 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- VenglustatGZ402671Phase 35 trials
Sanofi · Fabry Disease, Gaucher's Disease Type III, Gaucher Disease Type 1
- LucerastatPhase 32 trials
Idorsia Pharmaceuticals Ltd. · Fabry Disease
- 4D-310Phase 22 trials
4D Molecular Therapeutics · Fabry Disease
- AMT-191Phase 21 trial
UniQure Biopharma B.V. · Fabry Disease
- EXG110Phase 21 trial
Guangzhou Jiayin Biotech Ltd · Fabry Disease
- HM15421GC1134APhase 21 trial
GC Biopharma Corp · Fabry Disesase
- ST-920Phase 21 trial
Sangamo Therapeutics · Fabry Disease
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.